NCT05864079已完成不适用
Serum Levels of Developmental Endothelial Locus-1 and Its Relationship With Platelet Count and Soluble P-selectin in Overweight and Obese Subjects
Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2023年6月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 66
- 试验地点
- 1
- 主要终点
- Serum Developmental endothelial locus-1 levels
研究概览
简要总结
This observational study aims to detect serum levels of Developmental Endothelial Locus-1 (DEL-1), Platelet Count, and Soluble P-selectin (sP-sel) in Overweight and Obese Subjects. The main questions it aims to answer are:
- Is there a difference in serum DEl-1 levels in overweight and obese subjects compared to normal subjects?
- Are there any relations between serum DEL-1 levels, sP-sel, and platelet count in overweight and obese subjects ?
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Male patients.
- •Age (18-65) years.
- •Healthy overweight and subjects.
排除标准
- •Patients with cardiovascular diseases.
- •Diabetic patients.
- •Previous history of thrombo-embolic diseases.
- •Patients with hyperthyroidism.
- •Patients with any type of malignancy.
- •Underlying hepatic or renal failure.
- •Major surgery within 60 days.
结局指标
主要结局
Serum Developmental endothelial locus-1 levels
时间窗: 6 months
Serum developmental endothelial locus-1 in normal-weight, overweight, and obese subjects
Serum Soluble P-selectin levels
时间窗: 6 months
Serum Soluble P-selectin in normal-weight, overweight, and obese subjects
Platelet count
时间窗: 6 months
platelet count in venous blood samples in normal-weight, overweight, and obese subjects
次要结局
未报告次要终点
研究者
Asmaa Abdel-mageed Muhammed
Lecturer
Aswan University Hospital
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Pilot Study DiaDEPType1diabetesDiabetes Mellitus, Type 1NCT03912012Hospices Civils de Lyon23
尚未招募
不适用
Blood test for endothelin as marker for severe COVID 19 related diseaseCTRI/2021/07/034933All india Institute of Medical Science Rishikesh
已完成
不适用
Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA SequencingProliferative Diabetic RetinopathyDiabetic MaculopathyCirculating Endothelial CellsDiabetesDiabetes MellitusNCT05169502Aarhus University Hospital40
终止
2 期
A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast CancerBreast CancerNCT00845910Hoffmann-La Roche22
终止
不适用
Validation of Circulating Endothelial Cells and Microparticles in YouthBariatric Surgery CandidateChildhood ObesityNCT01508598University of Minnesota390